- HUMAN Diagnostics Worldwide
- Institutional Customers
- Solutions
- Non-communicable Diseases and Occupational Health
Non-communicable Diseases and Occupational Health
The listed items are CE-marked and comply with the strict requirements of the European IVD directive. Exceptions are clearly flagged.
Autoimmune diseases
HUMAN provides a very broad portfolio of diagnostic solutions for the assessment of Autoimmune diseases. Especially in resource limited settings with restricted access to highly trained personnel the employment of specific Line Immuno Assays reveal reliable diagnosis without performing Immuno Fluorescence Techniques (IFT). For more information on HUMAN Autoimmune Diagnostics solutions follow this link.
Cancer management
Type | Description | Product name |
---|---|---|
Rapid tests | For the detection of prostate specific antigen (PSA) | Hexagon PSA |
ELISA | For cancer monitoring |
|
CLIA |
For cancer monitoring |
AFP, CA 125 Ag, CA 15-3 Ag, CA 19-9 Ag,
|
Cardiovascular diseases
Type | Description | Product name |
---|---|---|
Urine test strips | For the detection of renal micro-vascular protein leakage (Albumine to Creatinine ratio) |
Glucose (GOD method or Hexokinase method) Clinical chemistry analyzer HumaLyzer 4000 in combination with solar charge and rechargeable battery HumaPower (accessories) |
Rapid test |
For the qualitative detection of Troponin I after suspected myocardial damage |
|
Assessment of risk and/or extend of cardiovascular diseases | Even in remote areas or regions with minimal infrastructure | HUMAN clinical chemistry reagents:
CK/CK-MB, LDL, HDL, Cholesterol, |
Diabetes
HUMAN provides an unprecedented variety of diagnostic solutions for diabetes care: Diagnosis, monitoring and assessment of compliance as well as long-term sequelae.
Type | Description | Product name |
---|---|---|
Urine test strips | For the detection of glucose in urine | |
Urine test strips |
For the detection of renal micro-vascular protein leakage (Albumine to Creatinine ratio) |
Combina 13 for visual or semi-automated reading In combination with semi-automated reader Combilyzer13
|
Point of Care | For the determination of blood glucose levels and/or parameters of metabolic syndrome | |
Point of Care | For the determination of HbA1c for diagnostic, monitoring and compliance assessment purposes | HumaMeter A1c |
HPLC system | For the determination of HbA1c for diagnostic, monitoring and compliance assessment purposes | HumaNex A1c Variant |
General assessment of health status
Type | Description | Product name |
---|---|---|
Testing for basic and/or comprehensive metabolic panel | Even in remote areas or regions with minimal infrastructure |
HUMAN clinical chemistry reagents: Glucose, Calcium Enzymatic Electrolytes: |
Measurement of electrolytes |
via ISE |
|
Blood count testing | Assessment of full 3-part CBC (complete blood count) even in remote areas or regions with minimal infrastructure | 3-part diff systems HumaCount 30TS and HumaCount 80TS in combination with solar charge and rechargeable battery HumaPower (accessories) |
Blood count testing | Assessment of full 5-part CBC (complete blood count) with one drop of capillary or venous blood | HumaCount 5D |
Hemostasis assessment
Routine panel of screening parameters for diagnostic assessment of blood disorders related to coagulation and fibrinolysis. These assays are being performed to determine the risk of exceeded bleeding (like childbirth or surgery) as well as to determine levels after heart attack.
|
Description | Product name | |
---|---|---|---|
Clot assessment | For determination of prothrombin time (PT) by investigation of the extrinsic pathway | ||
Clot assessment |
For determination of the activated partial thromboplastin time (aPTT) by investigation of the intrinsic pathway |
||
Clot assessment | For determination of the thrombin time (TT) for the basic screening profile | Hemostat Thrombin Time | |
Clot assessment | For determination of fibrin clot formation (Clauss Method) to identify fibrinogen defects | Hemostat Fibrinogen | |
Turbidimetric assay | For immunologic determination of D-dimer for exclusion of deep vein thrombosis of the leg or pulmonary embolism | Hemostat D-Dimer |